Abivax (ABVX) Ending Cash Balance (2021 - 2026)
Abivax's Ending Cash Balance came in at $443.17 million for Q2 2026, up 520.0% from $71.47 million a year earlier but down 19.0% from the prior quarter.
Powered by 
Analysis
Abivax (ABVX) Ending Cash Balance (2021 - 2026) Analysis & Trends
For FY2025, Abivax's Ending Cash Balance was $44.81 million, down 24.4% from FY2024.
- Ending Cash Balance carries a four-year compound annual growth rate of -84.0% (FY2021 to FY2025).
- Going back by year, Ending Cash Balance was $59.27 million in FY2024 (-100.0%), $278.85 billion in FY2023 (+870.6%), $28.73 billion in FY2022 (-58.2%) and $68.74 billion in FY2021.
- The five-year range for quarterly Ending Cash Balance is $44.81 million (Q4 2025) to $278.85 billion (Q4 2023).
- Year-over-year, Ending Cash Balance increased in three of the last seven quarters, with growth averaging 128.6%.
- The fastest year-over-year change in Ending Cash Balance over five years came in Q4 2023 (growth of 870.6%), and the weakest in Q4 2024 (a decline of 100.0%).
- Business Quant data shows ABVX's Ending Cash Balance at $547.13 million (Q1 2026), $44.81 million (Q4 2025) and $691.81 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Ending Cash Balance (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | 4.89 Bn |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 16.91 Bn |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | 10.77 Bn |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 9.65 Bn |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | 7.94 Bn |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 13.19 Bn |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | 6.44 Bn |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 1.88 Bn |
| 10 | Abivax | 7.07 Bn | 4.69 Bn | - | 443.17 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 443.17 Mn |
| Mar 31, 2026 | 547.13 Mn |
| Dec 31, 2025 | 44.81 Mn |
| Sep 30, 2025 | 691.81 Mn |
| Jun 30, 2025 | 71.47 Mn |
| Mar 31, 2025 | 112.11 Mn |
| Dec 31, 2024 | 59.27 Mn |
| Sep 30, 2024 | 201.56 Mn |
| Jun 30, 2024 | 238.07 Mn |
| Mar 31, 2024 | 260.80 Mn |
| Dec 31, 2023 | 278.85 Bn |
| Dec 31, 2022 | 28.73 Bn |
| Dec 31, 2021 | 68.74 Bn |
API Access
Abivax Ending Cash Balance API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ending-cash-balance&ticker=ABVX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ending-cash-balance", "ticker": "ABVX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ending-cash-balance&ticker=ABVX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();